Genome-wide Association Studies-GWAS
Pharmacogenomics: Identification of New Drug Targets
Epistasis Analysis
Genetic Screens
Pharmacogenetics and Pharmacogenomics: Overview
Background and Environment Affect Phenotype
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 20, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Sergey V Nuzhdin1, Maren L Friesen, Lauren M McIntyre
1University of Southern California, Program in Molecular and Computational Biology, Department of Biology, Los Angeles, CA 90089, USA. snuzhdin@usc.edu
This study merges genome-wide association studies (GWAS) with gene regulatory networks (GRNs) using structural equation modeling (SEM). This approach quantifies molecular pathways underlying phenotypic variation in natural populations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: